A Study Comparing the Effects of Trimbow to Fostair in COPD
Status:
Completed
Trial end date:
2019-08-06
Target enrollment:
Participant gender:
Summary
A randomised, open label 2-way cross-over study to compare the effects of inhaled
Beclometasone/Formoterol/Glycopyrronium (TRIMBOW) pMDI to Beclometasone/Formoterol (FOSTAIR)
pMDI on hyperinflation and expiratory flow limitation in moderate to severe chronic
obstructive pulmonary disease (COPD).